No Detail Found!

Nalbuphine prevents haemodynamic response to endotracheal intubation

Author(s)
Muhammad Ahsan-ul-HaqE Department of Anaesthesia, Military Hospital, Rawalpindi, Pakistan.
Etizaz Haider Kazmi Department of Anaesthesia, Military Hospital, Rawalpindi, Pakistan.
Zahid Akhtar Rao Department of Anaesthesia, Military Hospital, Rawalpindi, Pakistan.
Abstract
Objective: To determine the efficacy of nalbuphine in preventing the increase in heart rate and mean arterial pressure in response to laryngoscopy and orotracheal intubation. Design: A comparative trial. Place and Duration of Study: Department of Anaesthesia, Pakistan Naval Hospital Shifa, Karachi, Pakistan, from January 2001 to January 2002. Patients and Methods: Forty healthy patients having general anaesthesia for elective surgery, were selected by convenient sampling to receive either saline [group I (control group); n= 20] or nalbuphine 0.2mg/kg; (group II; n = 20) as a bolus dose, 5 minutes before laryngoscopy. Double blinding was done as the patient as well as the researcher was not aware of which study drug was being given. Heart rate (HR) and mean arterial pressure (MAP) were measured before induction of anaesthesia (time 1), just after intubation (time 2), then after every minute upto 5 minutes (time 3-7) and after 10 minutes of intubation (time 8). Twenty percent rise in heart rate (HR) and mean arterial pressure (MAP) was considered as significant. Data were analyzed by using SPSS version 10. Student’s t-test was used for the significance of parameters at p < 0.05 and analysis of variance test (ANOVA) was interpreted for group analysis of the parameters. Results: There was a significant increase (p <0.05) in heart rate (53.4%) in group I after intubation at time 2 compared with baseline at time 1, as compared to group II (15.5%). The HR gradually decreased during time 3 to 8 but still remained slightly higher than group II. MAP also increased significantly (p <0.05) in group I, at time 2 (43.6%) compared with baseline at time 1 as compared to group II (10.5%). The MAP also gradually decreased during time 3 to 8 but remained on slightly higher level than group II. Conclusion: Nalbuphine 0.2mg/kg prevented a marked rise in heart rate and mean arterial pressure associated with laryngoscopy and orotracheal intubation.
Publication Details
Page(s) 668-670
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 15, Issue: 11, Year: 2005

Request the full text from PASTIC

Keywords
Induction, Opioid analgesics, Nalbuphine, Orotracheal Intubation, Haemodynamic Response, Anaesthetic techniques
References
.1994 .. JAnaestb, 73 : 537-9.
. .A comparisoonftheanalgeseicffecot intramusculnaarlbuphineand morphinein patientswit postoperatpiavienJ. Pharmacol Exp TherASlQ-, 204 : 487-96.
.2004 .Reducingcardiovasculraersponsteoslaryngoscoapnydtrache intubationa: comparisonof equipotendtosesoftramado nalbuphinaend pethidinew. ithplaceboM.iddle East J Anestbesiol, 17 : 1023-36.
0

Citations

0

Downloads

66

Views